ClinConnect ClinConnect Logo
Search / Trial NCT06676059

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Launched by NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) · Nov 5, 2024

Trial Information

Current as of May 13, 2025

Recruiting

Keywords

Alcohol Substance Use Digital Phenotyping

ClinConnect Summary

The SMART-r trial aims to better understand why many adults struggle to stay in treatment for alcohol and substance use and why they often return to using substances shortly after starting. Researchers will collect information from adults who have used drugs or alcohol in the last month and have an Android smartphone. This study is open to anyone aged 18 and older living in the U.S. who can complete online surveys and understands English.

Participants will download an app called TTRU-Curtis AWARE, which will run quietly on their phones to gather data about their daily activities, like how often they use their phone and how much they move around. Every day, participants will answer a quick survey about their mood and substance use from the previous day, which should take less than five minutes. Once a month, they'll fill out a longer survey about their personal life and feelings. This information will help researchers learn more about the challenges people face in staying sober and how to improve treatment programs in the future.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • In order to be eligible to participate in the repository, an individual must meet all of the following criteria:
  • Must understand and be willing to complete an online informed consent process.
  • Be an adult aged 18 or older.
  • Self-report alcohol or other drug use within the past 30 days.
  • Have an Android smartphone as their primary mobile phone.
  • --The TTRU-CURTIS AWARE App does not have iPhone iOS functionality.
  • Have a minimum of 500 sent text messages and 1000 words exchanged through SMS (text messages).
  • Be willing to adhere to the procedures, including downloading the AWARE app onto their smartphone and keeping it active throughout the data collection period, completing baseline questionnaires, daily diary EMAs, and follow-up surveys.
  • Understand and write in English.
  • --This exclusion criterion is included because future research on the data collected will include linguistic analysis. all linguistic analyses, we remove rare words (e.g., words must be said by at least 95% of participants). Additionally, there are cultural differences across languages and, thus, interpreting language results across more than one language becomes difficult. As a result, we must keep analysis limited to a single language (English), since words in other languages will not meet that criteria.
  • Live in the United States.
  • EXCLUSION CRITERIA:
  • An individual who meets any of the following criteria will be excluded from participation in this repository:
  • -Any impairment severe enough to preclude informed consent or valid self-report.

About National Institute On Drug Abuse (Nida)

The National Institute on Drug Abuse (NIDA) is a leading federal agency within the U.S. Department of Health and Human Services, dedicated to advancing the understanding of drug abuse and addiction through rigorous scientific research. NIDA's mission encompasses the exploration of the biological, behavioral, and social aspects of substance use disorders, facilitating the development of effective prevention and treatment strategies. By funding and conducting innovative clinical trials, NIDA aims to translate research findings into practical solutions that improve public health and inform policy, ultimately contributing to the reduction of substance-related harm in communities across the nation.

Locations

Baltimore, Maryland, United States

Patients applied

NW

WS

2 patients applied

Trial Officials

Brenda Curtis, Ph.D.

Principal Investigator

National Institute on Drug Abuse (NIDA)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported